greeksoup/ stock research

National Healthcare (NHC) FY2021 results: revenue $1.1 billion, up 4.5% on the year

National Healthcare Corp. (NHC) reported revenue of $1.1 billion for fiscal 2021, the year ended 31 December 2021, up 4.5% on the year before. Net income was $139 million, up 231.0%, and diluted earnings per share $8.99. The figures are the company's own, from the 10-K it filed with the SEC on 18 February 2022.

Revenue
$1.1 billion
+4.5% on the year
FY2016FY2021
Operating margin
4.7%
4.7% a year earlier
FY2016FY2021
Net income
$139 million
+231.0% on the year
FY2016FY2021
Diluted EPS
$8.99
+230.5% on the year
FY2016FY2021

this yearthe year beforeHover a bar for its figure.

The year in brief

The quarters: Q4 FY2021

Income statement (profit and loss)

$ millionFY2021FY2020FY2019On the yearLast 8 years
Revenue1,0741,028996+4.5%
Operating income50.948.249.0+5.8%
Operating margin4.7%4.7%4.9%
Interest expense0.81.43.1-39.6%
Income tax11.010.420.0+5.0%
Net income13941.968.2+231.0%
Net margin12.9%4.1%6.8%
Diluted EPS$8.99$2.72$4.44+230.5%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2021FY2020FY2019On the yearLast 8 years
Operating cash flow62.4203100-69.3%
Capital expenditure39.421.926.4+80.1%
Free cash flow23.018173.7-87.3%
Free cash flow margin2.1%17.6%7.4%
Cash from investing-65.9-63.9-14.3
Cash from financing-35.3-41.9-79.7
Depreciation and amortisation40.742.042.4-3.2%
Share-based compensation2.62.51.9+6.8%
Buybacks0.80.10.9+1,477.4%
Dividends paid32.031.931.2+0.3%
Dividend per share$2.11$2.08$2.06+1.4%
Diluted shares, weighted15m15m15m+0.3%
Shares outstanding at period end15m15m15m+0.5%

Balance sheet

$ millionFY2021FY2020FY2019On the yearLast 8 years
Shareholders' equity903795779+13.6%
Non-controlling interest5.53.10.5+77.0%
Debt0.00.010.0
Operating lease liabilities129154179-16.3%
Finance lease liabilities5.810.515.0-44.5%
Other liabilities361400304-9.8%
Total liabilities and equity1,4031,3621,287+3.0%
Fixed assets521520535+0.1%
Goodwill16821.321.0+688.6%
Intangible assets7.00.0n/a
Investmentsn/an/a279
Securities held for sale or to maturity172190n/a-9.3%
Cash and equivalents10814750.3-26.8%
Receivables96.189.793.0+7.2%
Inventory8.68.87.4-2.3%
Other assets323385300-16.2%
Total assets1,4031,3621,287+3.0%

10-K for the year ended 31 December 2021, filed 18 February 2022: the filing.